Trial Details
TERMINATEDBasic Information
| Clinical ID | c1366 |
|---|---|
| Identifier | NCT03650413 |
| Trial Title | An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: UTTR1147A |
Participant Information
| Sponsor | Genentech, Inc. |
|---|---|
| City | Greenville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2019-01-14 |
|---|---|
| Primary Completion Date | 2022-07-12 |
| Completion Date | 2022-07-12 |